运动通过其对炎症和氧化应激的作用来减少无脂蛋白E缺陷小鼠的超脂血症诱导的心脏损伤
Zuowei Pei1,2, Jun Ji1, Yanyan Gao1
1Department of Central Laboratory, Central Hospital of Dalian University of Technology, No. 826 Xinan Road, Dalian, 116033, China.
Scientific reports
|June 5, 2023
概括
在高脂血症模型中,运动训练减轻了心脏损伤. 这项对阿波利波蛋白E缺乏的小鼠的研究表明,运动改善了抗氧化剂水平,并减少了纤维化和亡,突出显示了它对心血管疾病的保护作用.
科学领域:
- 心血管疾病研究研究
- 运动生理学 运动生理学
- 分子生物学分子生物学
背景情况:
- 心血管疾病对全球的健康构成重大负担.
- 运动训练是针对各种心血管疾病的既定,基于证据的治疗方法.
- 超脂血是导致心脏损伤的主要危险因素.
研究的目的:
- 在超脂血症引起的心脏损伤的小鼠模型中研究运动训练的心脏保护作用.
- 评估运动对氧化应激,纤维化,亡以及心脏关键分子标记物的影响.
主要方法:
- 缺乏阿波蛋白E (ApoE-/-) 的小鼠在12周内被食正常饮食 (ND) 或高脂肪饮食 (HFD).
- 两组饮食中的小鼠被进一步分为静坐或运动训练 (游泳) 小组.
- 心脏组织病理学,血清生物化学和蛋白质/基因表达 (NOX4,NRF2,SIRT1,TGF-β,HO-1,原III等) 进行了分析.
主要成果:
- 与ND的小鼠相比,在HFD中的小鼠表现出增加的氧化应激,心脏纤维化和亡.
- 与静止型HFD小鼠相比,HFD小鼠 (HFD+E) 的运动训练显著提高了血清抗氧化剂水平 (SIRT1,GSH-Px,SOD).
- 运动训练减轻了病理性心脏变化,减少了氧化应激和纤维化,并减少了HFD小鼠的亡.
结论:
- 运动训练在ApoE-/-小鼠中显示出显著的保护作用,防止高脂血症引起的心脏损伤.
- 运动提高了抗氧化能力,并减轻了与心脏损伤有关的有害分子通路.
- 研究结果支持运动作为一种治疗策略,用于管理与高脂血症相关的心血管并发症.
相关概念视频
Exercise and Cardiovascular Response
874
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
874
Coronary Artery Disease I: Introduction
33
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13


